CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.
Novo Nordisk
since
auto-detected in 91 stories
17 hours ago
18 days ago
Europe stocks pop 2% as Trump tariff exemptions boost sentiment; Novo Nordisk up 4%
European equities saw a sharply higher open, with investors still reeling from one of the wildest weeks for markets on record.
45 days ago
German stocks lift European markets higher ahead of debt reform vote; Novo Nordisk gains 3.5%
European markets opened in positive territory on Tuesday, with investor focus on the German government as it votes on historic debt reforms.
52 days ago
European markets open lower; Novo Nordisk, Novartis retreat
European markets opened lower as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump's trade policies.
53 days ago
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Stocks making the biggest moves premarket: JPMorgan Chase, Coinbase, Redfin, Novo Nordisk
These are the stocks posting the largest moves in premarket trading.
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
58 days ago
Amgen starts two critical late-stage trials for weight loss drug MariTide
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
Amgen starts two critical late-stage trials for weight loss drug MariTide
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.